Fact-checked
х

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.

We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.

If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.

Lazy eye: what is amblyopia and how is it treated?

Medical expert of the article

Alexey Krivenko, medical reviewer, editor
Last updated: 27.10.2025

Amblyopia is a neurodevelopmental vision disorder in which one (rarely both) eyes have diminished vision, even though the ocular structures may be anatomically normal. The problem lies not in the eye itself, but in how the cerebral cortex learns to process visual input in early childhood: if one eye receives a lower-quality image (squint, unequal diopters, clouding), the brain suppresses its contribution, resulting in a persistent decline in visual acuity. [1]

Classically, three mechanisms are distinguished: strabismic (due to strabismus, the brain "turns off" the deviating eye to get rid of double vision), anisometropic (a large difference in refraction between the eyes makes the image of one eye constantly "blurry") and deprivation (vision "has not developed" due to an obstruction to light - congenital cataracts, ptosis, etc.). All three options lead to competition between the eyes and suppression of the signal from the "weak" eye at the level of the visual cortex. [2]

The critical period of vision development occurs in the first years of life, so early detection and treatment determine the prognosis. The timing is particularly "tough" for the deprivation form: with dense congenital cataracts, delaying surgery dramatically increases the risk of irreversible amblyopia. [3]

Current guidelines from the American Academy of Ophthalmology (AAO) confirm that amblyopia is the leading preventable cause of monocular vision loss in children; timely screening and standardized treatment improve visual outcomes and quality of life. [4]

Who needs vision screening and when?

International recommendations agree: all children aged 3-5 years should be screened at least once to detect amblyopia or its risk factors (strabismus, anisometropia, medial opacities). In the United States, this is a Level B recommendation from the USPSTF Task Force; for children under 3 years of age, evidence is insufficient, but pediatricians and ophthalmologists often use photoscreening/autorefractometry if there is a suspicion. [5]

Screening includes visual acuity testing using age-appropriate charts with symbols/pictures, eye position assessment, red reflex, and refraction (instrumental methods). If the test fails or there are clear signs of strabismus, the child is referred to a pediatric ophthalmologist for a full diagnosis and glasses selection. [6]

The earlier problems are detected, the greater the plasticity of the visual system and the less treatment is required. After 7-8 years, neuroplasticity declines, but treatment is still possible; it just takes longer and yields smaller benefits. [7]

Screening is also important because amblyopia is often unnoticeable in everyday life: the child uses the "strong" eye and doesn't complain. Only a targeted examination of each eye separately can detect latent vision loss. [8]

Table 1. Who, when and how to screen

Age What are we doing? For what
6-36 months Red reflex examination, eye alignment, instrumental screening if available Early detection of risk factors
3-5 years Visual acuity test +/- instrumental screening USPSTF Recommendation: Catch Amblyopia Early [9]
Over 5 years old If you haven't been screened before or have complaints Don't miss late cases

Ophthalmologist's examination: what is checked?

Basic block: visometry of each eye using age-specific charts, objective refraction with cycloplegia (drops to "turn off" accommodation), examination of the anterior segment and fundus, assessment of binocularity and the presence/type of strabismus. The goal is to record baseline visual acuity and determine the cause of amblyopia (strabismus? Anisometropia? Clouding?). [10]

If deprivation (cataracts, dense ptosis) is suspected, urgent imaging/surgery is prescribed: in these cases, the window for preventing severe amblyopia is narrow. Even after the obstruction to light is removed, full-fledged amblyopic therapy (glasses + occlusion/atropine) will still be required. [11]

With anisometropia, the first, and often sufficient, step is properly fitted glasses: a significant percentage of children experience significant improvement in vision with correction alone over the course of weeks to months, and only then are "spits" (atropine) or a "patch" (occlusion) added if progress has stalled. This isn't a "wasted time," but a proven treatment option. [12]

It's important to agree on response criteria (how many lines were added), frequency of visits, and timing of the next step so that treatment isn't delayed and the family understands the purpose of each step. AAO guidelines recommend regular monitoring to adjust glasses and the occlusion/atropine regimen. [13]

Treatment: A Modern Step-by-Step Plan

Step 1. Glasses (optical correction)

In anisometropic and mixed amblyopia, glasses alone improve vision in most children: ≥2 lines of improvement in ~75%, and full resolution in ~25-30% for up to 30 weeks. Therefore, glasses are used to begin with, progress is monitored, and only after a plateau is active therapy added. [14]

Step 2. Occlusion or pharmacological penalization

If a plateau is reached with glasses, occlusion (covering the "strong" eye for part of the day) or atropine (1% drops that "blur" the strong eye's focus at near) are added. Large randomized PEDIG trials have shown that atropine and occlusion provide comparable benefits in moderate amblyopia in children aged 3-7 years; the choice depends on age, type of amblyopia, and tolerance. [15]

How many hours should the patch be applied? PEDIG data and subsequent reviews suggest a guideline of 2 hours/day for moderate amblyopia and 6 hours/day for severe amblyopia; a "full day" is rarely needed. Lower doses increase compliance and are almost as effective; some children with severe amblyopia may respond to even 2 hours/day. [16]

Additional options: Bangerter filters (translucent films placed on glasses for the "strong" eye) may be used as an alternative to occlusion in some patients; the evidence base is weaker, but this approach is convenient for some families. The decision is made by an ophthalmologist. [17]

Step 3: Support and relapse prevention

After achieving target visual acuity, the risk of relapse within the first year is approximately 25%. The risk is higher if long-term occlusion is abruptly discontinued. Therefore, the regimen is tapered gradually (for example, from 6 to 2 hours per day over several weeks), while monitoring is maintained. [18]

Table 2. What, when and why is prescribed

Stage What are we doing? Expected effect
1 Full prescription glasses (cycloplegia) Often sufficient for anisometropia: +2 lines or more in 6-30 weeks [19]
2a Occlusion 2 hours/day (moderate) or 6 hours/day (severe) Increased visual acuity, high evidence [20]
2b Atropine 1% (usually 1 drop on weekends or daily as prescribed) The effect is comparable to “patching” in moderate amblyopia [21]
3 Gradual abolition Reduction in the risk of relapse (~25% with abrupt discontinuation) [22]

What's New: Binocular and Play Therapies for Adults

In recent years, binocular (dichoptic) methods have been actively studied: games/videos in which each eye is shown elements of varying contrast, forcing the eyes to work together. The idea is attractive, but the results are mixed: in a number of RCTs, "games" did not show any worse results than classic "patching," and compliance with the games was often low; new protocols for 2024-2025 continue to search for effective modes that enhance "adhesion." For now, binocular approaches are a complement to, not a replacement for, occlusion/atropine. [23]

For adults, data are limited: classic occlusion after closing the "critical window" is generally ineffective. However, elements of plasticity revision (perceptual training, binocular tasks, VR) are being studied; in small studies, some adults have shown moderate improvements in contrast sensitivity/stereovision. This is still an experimental area, and expectations should be realistic. [24]

The key conclusion remains unchanged: the earlier basic treatment (glasses → occlusion/atropine) is started, the higher the chance of full recovery. New technologies are good as motivation and binocular skill enhancers, but they do not replace the fundamental steps. [25]

Common situations and practical answers

  • Is it necessary to perform strabismus surgery "immediately" to cure amblyopia?

The goal of the surgery is to align the eyes and restore binocular vision; amblyopia itself is treated with glasses and occlusion/atropine. Often, the vision of the "weak" eye is improved first, and then the surgical option is considered—this makes it easier to train binocular vision later. [26]

  • How do you know when the glasses have worked and it's time to add occlusion/atropine?

If the visual acuity of the "weak" eye has stopped improving with glasses over two consecutive visits (usually 6-8 weeks), a plateau has been reached; we add active therapy. This is standard PEDIG/AAO logic. [27]

  • How much does it cost to treat in total?

Typically, the months are: a spectacle phase (up to 30 weeks) + several months of occlusion/atropine with gradual withdrawal. It is important not to stop abruptly and to return for follow-up, as one in four patients may relapse in the first year without observation. [28]

  • What about the side effects?

Occlusion may cause skin irritation/child unwillingness; atropine may cause photophobia, blurring of vision near the "strong" eye, and, rarely, systemic reactions. All regimens are safe when properly selected and monitored; report any discomfort to your doctor—modes can be flexibly adjusted. [29]

Table 3. Myths and facts

Myth How it really is
"After 7 years it is too late to treat." Later it is more difficult, but improvement is possible; it is just that the pace and limits are lower. [30]
"Only the 'sealing' works, the drops are weaker." Atropine was non-inferior to occlusion for moderate amblyopia in RCTs.[31]
"It needs to be taped all day long." For most people, 2-6 hours/day is sufficient: higher adherence, comparable effect. [32]
"If your vision has evened out, you can cancel everything immediately." Abrupt discontinuation increases the risk of relapse; tapering off gradually. [33]

What do need to examine?